MT-401

· Marker Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MT-401, covering 2025-10-30 to 2025-10-30. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of MT-401 in Patients With AML Following Stem Cell Transplant [Phase 2]